Viewing nowCombinationPitarow F Tablet 2/160 milligrams (Pitavastatin, Fenofibrate)
Fenofibrate Micronized 160mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Jongkundang

MFDS item code 202501048 · Approved 2025.04.30 · Insurance code 643309840
Treatment of mixed dyslipidemia in adults at high risk of coronary heart disease
Pitavastatin 2mg as monotherapy effectively lowers LDL cholesterol levels in high-risk adult patients with coronary artery disease. However, in cases of mixed dyslipidemia, there may be a need for additional management of this aspect as triglyceride levels are elevated and HDL cholesterol levels are low. This medication is primarily used to reduce the risk of cardiovascular diseases by modulating LDL cholesterol.
As the recommended dose, take 1 tablet once daily immediately after a meal.
This medication is used to lower blood lipid levels. During treatment, muscle-related symptoms such as pain, weakness, and cramps may appear; if these symptoms occur, you should immediately consult a healthcare professional. Particularly, elderly patients, women, patients with impaired kidney function, uncontrolled hypothyroid patients, patients with a history or family history of muscle diseases, and patients with alcohol dependence are at a higher risk for muscle damage and should be cautious. When taken with other lipid-lowering agents or certain medications, the risk of muscle toxicity may increase, so you must inform your healthcare professional about all medications you are taking. If there are issues with liver function or a history of liver disease, regular liver function tests are required, and if symptoms of hepatitis or significant liver enzyme elevations occur, the medication should be discontinued. This medication is contraindicated in patients with moderate to severe renal impairment, and mild renal impairment patients should take it with caution. There is a risk of pancreatitis with this medication; therefore, patients with a history of pancreatitis or those showing symptoms should consult a healthcare professional immediately. Pregnant or potentially pregnant women, nursing mothers, and children under 18 years of age should not take this medication. This medication may rarely cause skin rashes, itching, severe skin reactions, or allergic responses; if unusual symptoms occur, the patient should immediately discontinue use and consult a doctor. Caution is necessary as dizziness may occur while driving or operating machinery. Before and during treatment, regular blood tests and kidney and liver function assessments are necessary, and if there is no therapeutic effect, treatment should be discontinued. In case of overdose, there is no specific antidote; symptomatic and supportive treatment is required. This medication must be taken with food, and during storage, it should be placed in a location out of reach of children and kept in its original container.
nasopharyngitis, upper respiratory tract infection, increased ALT, increased AST, increased GGT, abnormal liver function tests, gastroesophageal reflux disease, nausea, headache, dizziness, increased CPK, hypertension, chronic gastritis, erosive gastritis, decreased hemoglobin, decreased white blood cell count, decreased platelet count, decreased granulocytes, leukopenia, eosinophilia, increased white blood cell count, elevated globulin, positive Coombs test, anemia, hypersensitivity, headache, fatigue, dizziness, stiffness, drowsiness, insomnia, heavy sensation, paralysis, thromboembolism, interstitial lung disease, gastrointestinal symptoms (abdominal pain, nausea, vomiting, diarrhea, bloating), pancreatitis, thirst, dyspepsia, abdominal bloating, constipation, stomatitis, loss of appetite, glossitis, nausea, gastrointestinal discomfort, increased transaminases, cholelithiasis, jaundice, complications of cholelithiasis, elevated bilirubin, increased cholinesterase, increased AST, increased ALT, increased γ-GT, increased ALP, increased LDH, decreased aldosterone, increased aldosterone, increased adrenocorticotropic hormone, increased cortisol, decreased testosterone, severe skin reactions, skin hypersensitivity, rash, pruritus, urticaria, alopecia, photosensitivity, muscle disorders, myalgia, myositis, muscle cramps, muscle weakness, rhabdomyolysis, myopathy, muscle cramps, increased myoglobin, increased CPK, weakness, increased frequency of urination, increased BUN, increased serum creatinine, sexual dysfunction, increased serum homocysteine levels, increased hematuria, palpitations, fatigue, skin tenderness, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, urinary hematuria, increased uric acid levels, elevated serum potassium and phosphorus, taste disorders, discolored urine, malaise, positive antinuclear antibodies, alopecia, hypersensitivity, angioedema, urticaria, erythema
Not everyone experiences these, and they can vary from person to person.
This medication is susceptible to air and moisture, so it must be stored in a tightly closed container. It should be maintained at room temperature, between 1 degree and 30 degrees Celsius, for optimal efficacy.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFenofibrate Micronized 160mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Jongkundang
CombinationFenofibrate Micronized 160mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
Genupharm Co., Ltd.
CombinationFenofibrate Micronized 160mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationFenofibrate Micronized 160mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Daewoong Pharmaceutical
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.